Yngvild Nuvin Blaker

Author

Oslo University Hospital

Also Known As

Y. N Blaker, Y. N. Blaker, Yngvild Blaker, Yngvild N Blaker, Yngvild N. Blaker, Yngvild Nuvin Blaker

Publications

591

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo Karolinska University Hospital Karolinska Institutet Rigshospitalet

About

Yngvild Nuvin Blaker is an author at Oslo University Hospital specializing in cancer research, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	170
2	Immunology	4	4	170
3	Pathology	4	4	170
4	Engineering	1	1	13
5	Cell Biology	1	1	23

Yngvild Nuvin Blaker

Publications

563

Citations

H-Index

Page 1

	Year	Citations
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Blood	2021	121
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli, The Lancet Haematology Lymphoid NeoplasiaMedicineImmunologyFollicular LymphomaPathology	2018	112
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma Sarah E. Josefsson, Klaus Beiske, Yngvild Nuvin Blaker, Cancer Immunology Research	2019	108
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era Yngvild Nuvin Blaker, Signe Spetalen, Marianne Brodtkorb, British Journal of Haematology	2016	68
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma Hakan Köksal, Pierre Dillard, Sarah E. Josefsson, Blood Advances	2019	58
The <scp>MCL</scp>35 gene expression proliferation assay predicts high‐risk <scp>MCL</scp> patients in a Norwegian cohort of younger patients given intensive first line therapy Harald Holte, Klaus Beiske, Merrill Boyle, British Journal of Haematology	2018	26
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Ivana Spasevska, Ankush Sharma, Chloé B. Steen, Blood Advances T-regulatory CellImmunologyImmune RegulationPathologyRegulatory T Cells	2023	23
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients Lasse Hjort Jakobsen, Fredrik Ellin, Knut B. Smeland, British Journal of Haematology ImmunodeficienciesImmunologyPathologyEarly NormalizationMyc Gene Translocation	2020	22
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series Jillian F. Wise, Sigve Nakken, Chloé B. Steen, Blood Advances EngineeringImmunologyPathologyTumor BiologyHematological Malignancy	2020	13
Computerized image analysis of the Ki‐67 proliferation index in mantle cell lymphoma Yngvild Nuvin Blaker, Marianne Brodtkorb, John Maddison, Histopathology	2014	12

Page 1